Sun Pharma inks MoU with Takeda to introduce gastrointestinal drug in India
Shares of Sun Pharma were trading 0.69 per cent up at Rs 1,480.55 apiece on the BSE. 2 min read
Continue reading
Tag: gastroesophageal reflux disease
Granules India get US FDA’s approval for another ANDA capsule, shares dip
Granules India Limited announced that the USFDA approved its Abbreviated New Drug Application (ANDA) for Esomeprazole Magnesium Delayed-Release Capsules USP,
Continue reading